Molecular analysis of apo(a) fragmentation in polygenic hypercholesterolemia: Characterization of a new plasma fragment pattern

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 8, 2001, Pages 1353-1358

  Gonbert, Sophie ^a   Saint Jore, Bruno ^a   Giral, Philippe ^a   Doucet, Chantal ^a   Chapman, John ^a   Thillet, Jolle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apo(a); Hypercholesterolemia; Lp(a); Vascular disease

Indexed keywords

APOLIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOBLOTTING; KIDNEY CLEARANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RISK FACTOR; VASCULAR DISEASE;

EID: 0035572903     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0801.093654     Document Type: Article

References (30)

1. Atherothrombogenicity of lipoprotein(a): The debate
2. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
3. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulse-field electrophoresis
4. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: The distribution of null alleles is non-random
5. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine
6. Lipoprotein(a) in the nephrotic syndrome: Molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine
7. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure
8. Apolipoprotein(a) kringle 4-containing fragments in human urine: Relationship to plasma levels of lipoprotein(a)
9. Immunochemically detectable lipid-free apo(a) in plasma and in human atherosclerotic lesions
10. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease: Rapid communication
11. High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: Implications for plasma Lp(a) assay
12. Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation
13. Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia
14. Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia
15. Prediction of creatinine clearance from serum creatinine
16. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: The Stanislas cohort
17. Lipoprotein[a] in the chimpanzee: Relationship of apo[a] phenotype to elevated plasma Lp[a] levels
18. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo
19. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients
20. Characterization of five mouse monoclonal antibodies to apolipoprotein (a) from human Lp(a): Evidence for weak plasminogen reactivity
21. Metabolism of Lp(a): Assembly and excretion
22. Characterization of the N-terminal and C-terminal domains of human apolipoprotein(a): Relevance to fibrin binding
23. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans: Rapid publication
24. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect
25. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: Density profile, particle heterogeneity and apolipoprotein(a) phenotype
26. Lipoprotein(a) in homozygous familial hypercholesterolemia
27. Lipoprotein heterogeneity and apolipoprotein B metabolism
28. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase: Generation of mini-Lp(a) particles and apo(a) fragments
29. Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and apo(a) fragments
30. Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5: Potential relevance to lipoprotein(a) biology